Literature DB >> 20411061

Traumatic corneal flap displacement five years after laser in situ keratomileusis.

A Grezda1, V Mema, J Jaho, J Dai.   

Abstract

Laser in Situ Keratomileusis (LASIK) is the most common surgical procedure for the correction of refractive deviations. LASIK has been ongoing lately in our country, exclusively in private settings. This is the reason for which our clinic has no experience with LASIK procedure and complications following it. We are presenting a case of a 23 year-old female with traumatic flap displacement on the left eye, 5 years after the original LASIK operation. She was presented to our clinic on the 6th posttraumatic day. The patient was immediately operated and the flap repositioned. The case we present, is the only one treated to our clinic with such a vision-threatening complication of LASIK procedure.

Entities:  

Keywords:  LASIK; correction of refractive deviations; laser; trauma; traumatic corneal flap displacement

Year:  2010        PMID: 20411061      PMCID: PMC2843572     

Source DB:  PubMed          Journal:  Hippokratia        ISSN: 1108-4189            Impact factor:   0.471


  3 in total

1.  Late dislocation of LASIK flap following fingernail injury.

Authors:  M Srinivasan; Sangita Prasad; N Venkatesh Prajna
Journal:  Indian J Ophthalmol       Date:  2004-12       Impact factor: 1.848

2.  Cohesive tensile strength of human LASIK wounds with histologic, ultrastructural, and clinical correlations.

Authors:  Ingo Schmack; Daniel G Dawson; Bernard E McCarey; George O Waring; Hans E Grossniklaus; Henry F Edelhauser
Journal:  J Refract Surg       Date:  2005 Sep-Oct       Impact factor: 3.573

3.  Factors affecting corneal strip stroma-to-stroma adhesion.

Authors:  E P Perez; B Viramontes; P Schor; D Miller
Journal:  J Refract Surg       Date:  1998 Jul-Aug       Impact factor: 3.573

  3 in total
  1 in total

1.  Application of cold patch in relieving pain after transepithelial photorefractive keratectomy.

Authors:  Yuan Zeng; Yi Li; Jian-Hua Gao
Journal:  Pain Res Manag       Date:  2015-05-20       Impact factor: 3.037

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.